XML 120 R101.htm IDEA: XBRL DOCUMENT v3.22.4
Financing arrangements - Shelf Registration Statements and Other Facilities (Details)
1 Months Ended 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
renewal_option
Dec. 12, 2022
USD ($)
Dec. 31, 2021
USD ($)
Debt Instrument [Line Items]        
Commercial paper, maximum borrowing capacity $ 2,500,000,000 $ 2,500,000,000    
Commercial Paper 0 $ 0   $ 0
Annual commitment fees for syndicated, unsecured, revolving credit agreement   0.10%    
Horizon Therapeutics [Member]        
Debt Instrument [Line Items]        
Bridge credit agreement, initial amount 28,500,000,000 $ 28,500,000,000 $ 28,500,000,000  
Line of credit [Member]        
Debt Instrument [Line Items]        
Maximum current borrowing capacity under a syndicated, unsecured, revolving credit agreement 2,500,000,000 2,500,000,000    
Amount by which borrowing capacity under a syndicated unsecured revolving credit agreement may be increased upon our request at discretion of banks   $ 750,000,000    
Initial commitment term of each bank which is a party to the agreement   5 years    
Number of additional term extension options | renewal_option   2    
Additional period for extension of commitment term   1 year    
Amount outstanding under syndicated, unsecured, revolving credit facility $ 0 $ 0   $ 0
Line of credit [Member] | Secured overnight financing rate        
Debt Instrument [Line Items]        
Basis spread on variable rate 1.125%      
Description of variable rate basis one-month SOFR      
Line of credit [Member] | Federal Funds Purchased        
Debt Instrument [Line Items]        
Basis spread on variable rate 0.50%      
bridge credit agreement        
Debt Instrument [Line Items]        
Bridge credit agreement amount $ 0 0    
bridge credit agreement | Horizon Therapeutics [Member]        
Debt Instrument [Line Items]        
Bridge credit agreement amount $ 0 $ 0